Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

5 days ago 2
The acquisition brings a caller attack to treating allergic diseases to the company’s immunology pipeline.
Read Entire Article
  1. Homepage
  2. Technology
  3. Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion

Related

OpenAI Adds Another $12 Billion to Latest Funding Round

OpenAI Adds Another $12 Billion to Latest Funding Round

17 hours ago 2
OpenAI Closes Silicon Valley’s Largest-Ever Funding Round

OpenAI Closes Silicon Valley’s Largest-Ever Funding Round

17 hours ago 1
Mayor Mamdani announces return of TikTok app for NYC government

Mayor Mamdani announces return of TikTok app for NYC governm...

18 hours ago 1
Moon rocket and weather are on NASA's side for the first astronaut launch in decades

Moon rocket and weather are on NASA's side for the first ast...

19 hours ago 2
Oracle Lays Off Workers Amid Heavy AI Investment

Oracle Lays Off Workers Amid Heavy AI Investment

20 hours ago 4
Caltech Researchers Claim Radical Compression of High-Fidelity AI Models

Caltech Researchers Claim Radical Compression of High-Fideli...

20 hours ago 4

Popular

The Tiny Country Behind Some of Soccer’s Biggest Stars Is on the Brink of a First World Cup

The Tiny Country Behind Some of Soccer’s Biggest Stars Is on...

6 days ago 20
Who Will Yell at the Robot Umpires?

Who Will Yell at the Robot Umpires?

6 days ago 18
Nestlé says 413,793 KitKat candy bars stolen en route from Italy to Poland

Nestlé says 413,793 KitKat candy bars stolen en route from I...

3 days ago 17
The Best Fitness Gear to Achieve Your Goals, According to Professional Athletes and Trainers

The Best Fitness Gear to Achieve Your Goals, According to Pr...

6 days ago 14
Call out to volunteers to take part in bug survey

Call out to volunteers to take part in bug survey

3 days ago 13
About Us · Contact Us · Privacy Policy

© TOP Report - 2026